表紙
市場調查報告書

內臟器官晶片的全球市場:未來預測

Global Organ On A Chip Market Forecast 2019-2027

出版商 Inkwood Research 商品編碼 879086
出版日期 內容資訊 英文 129 Pages
商品交期: 2-3個工作天內
價格
Back to Top
內臟器官晶片的全球市場:未來預測 Global Organ On A Chip Market Forecast 2019-2027
出版日期: 2019年07月01日內容資訊: 英文 129 Pages
簡介

本報告提供全球內臟器官晶片 (Organ-on-a-Chip) 市場未來展望相關分析,提供產品的特性和市場基本結構,主要的促進·阻礙因素,市場整體及不同處方形態·各終端用戶·各產品種類·各地區的市場趨勢預測 (今後9年份),主要企業簡介等調查。

第1章 分析範圍

第2章 分析方法

第3章 摘要整理

第4章 市場動態

  • 市場定義和範圍
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第5章 內臟器官類別的市場

  • 肝臟
  • 心臟
  • 其他

第6章 各用途的市場

  • 藥物研發
  • 毒性檢驗
  • 其他

第7章 各終端用戶的市場

  • 製藥企業,生物科技企業
  • 教育·研究機關
  • 其他

第8章 主要分析指標

  • 波特的五力分析
  • 內臟器官晶片市場潛在力
  • 管理體制
  • 投資分析
  • 供應鏈分析
    • 原料供應商
    • 廠商
    • 經銷商
    • 終端用戶
  • 市場機會矩陣

第9章 各地區分析

  • 北美 (美國,加拿大)
  • 歐洲 (德國,法國,英國,義大利,西班牙等)
  • 亞太地區 (日本,中國,印度,澳洲,韓國等)
  • 其他的國家 (RoW:南美,中東·非洲)

第10章 競爭環境

  • 市場定位分析
  • 企業簡介
    • AXOSIM INC.
    • BEONCHIP
    • BIOMIMX SR
    • CN INNOVATIONS HOLDINGS LIMITED (CN BIO INNOVATIONS)
    • ELVEFLOW
    • EMULATE
    • FLUIGENT
    • HESPEROS
    • HUREL CORPORATION
    • INSPHERO AG
    • MIMETAS B.V.
    • NORTIS INC.
    • ORGANOVO HOLDINGS, INC.
    • SYNVIVO
    • TARA BIOSYSTEMS, INC.
    • TISSUSE GMBH
目錄
Product Code: 25663

KEY FINDINGS:

The Organ-on-a-Chip (OOC) is essentially 3D microfluidic cell culture chip with multiple channels, and it is sized similar to an AA battery with optical transparency which allows derive cellular and molecular level inferences based on the functionality, response, and behavior of the cells on the chip. The global Organ-on-a-Chip market is estimated to grow from $XX thousand in 2018 to $XX thousand by 2027, at a CAGR of 39.70% between 2019 and 2027.

Organ-on-a-Chip has the potential to serve as a new enabling platform for validation and identification of safety, efficacy, and sturdiness of possible targets timely in the pipeline for increasing the chances of success in clinical trials.

MARKET INSIGHTS:

The rise in the demand for early recognition of drug toxicity, technological advancements, and the growing usages of Organs-on-Chips for animal testing are the major drivers that are propelling the market advancement during the forecasting years. The technical hitches associated with Organs-On-Chips technology is the major factor that is hindering the market advancement. The design architecture of the OOC allows taking a step into the replicated conditions similar to the in vivo physiological environment at the same time it helps measure the barrier functions to determine further. But there are not many individuals who are yet not as experienced as necessary, which does withhold the market growth in one or another.

REGIONAL INSIGHTS:

Geographically, the global market for Organs-On-Chips is expanding profusely in many places which have been demarcated into several regions for market analysis, namely, into the Asia Pacific, Europe, North America and the remaining nations forming the Rest of World regional segment. In 2018, the majority of market share was captured by the North America segment in the global Organs-On-Chip market by geography. North America contributed approximately XX% of the market share in 2018 and is estimated to contribute the majority of share to remain at approximately XX% in 2027 as compared to 2018. The technology's increasing demand in drug screening and the upsurge in a number of key players operating in the regional market for OOCs in North America are majorly responsible for the impressive market growth.

COMPETITIVE INSIGHTS:

Emulate, Hurel Corporation, Elvelow, Fluigent, Organovo Holdings, Inc., InSphero AG, TissUse GmbH, CN Innovations Holdings Limited (CN Bio Innovations), Nortis Inc., SynVivo, AxoSim Inc., BiomimX S.r.l, TARA Biosystems, Inc., MIMETAS B.V., Hesperos, and BEOnChip are the major companies operating in the OOC market.

TABLE OF CONTENTS

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. LUNG ON CHIP ORGAN TYPE HOLDS THE LARGEST MARKET SHARE
    • 3.2.2. DRUG DISCOVERY IS THE FASTEST GROWING APPLICATION
    • 3.2.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE THE MAJOR END-USER OF THE ORGAN ON A CHIP TECHNOLOGY

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN THE DEMAND FOR EARLY DETECTION OF DRUG TOXICITY
    • 4.2.2. TECHNOLOGICAL ADVANCEMENTS
    • 4.2.3. GROWING USAGES OF ORGANS-ON CHIPS FOR ANIMAL TESTING
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. DIFFICULTIES ASSOCIATED WITH THE ORGANS-ON-CHIPS TECHNOLOGY
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. INCREASING R&D ACTIVITIES
    • 4.4.2. GROWING OPPORTUNITIES IN DRUG DEVELOPMENT
  • 4.5. MARKET CHALLENGES
    • 4.5.1. HIGH COST ASSOCIATED WITH THE ORGAN ON A CHIP DEVICES
    • 4.5.2. SHORTAGE OF SKILLED PERSONAL

5. MARKET BY ORGAN TYPE

  • 5.1. LIVER
  • 5.2. HEART
  • 5.3. LUNG
  • 5.4. OTHER ORGAN TYPE

6. MARKET BY APPLICATION

  • 6.1. DRUG DISCOVERY
  • 6.2. TOXICOLOGY RESEARCH
  • 6.3. OTHER APPLICATION

7. MARKET BY END-USER

  • 7.1. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 7.2. ACADEMIC AND RESEARCH INSTITUTES
  • 7.3. OTHER END-USER

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. THREAT OF COMPETITIVE RIVALRY
  • 8.2. ORGAN ON A CHIP MARKET POTENTIAL
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. INVESTMENT ANALYSIS
  • 8.5. SUPPLY CHAIN ANALYSIS
    • 8.5.1. RAW MATERIAL SUPPLIERS
    • 8.5.2. MANUFACTURERS
    • 8.5.3. DISTRIBUTORS
    • 8.5.4. END-USERS
  • 8.6. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. FRANCE
    • 9.2.2. GERMANY
    • 9.2.3. THE UNITED KINGDOM
    • 9.2.4. ITALY
    • 9.2.5. SPAIN
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. JAPAN
    • 9.3.2. CHINA
    • 9.3.3. INDIA
    • 9.3.4. AUSTRALIA
    • 9.3.5. SOUTH KOREA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET POSITION ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. AXOSIM INC.
    • 10.2.2. BEONCHIP
    • 10.2.3. BIOMIMX SRL
    • 10.2.4. CN INNOVATIONS HOLDINGS LIMITED (CN BIO INNOVATIONS)
    • 10.2.5. ELVEFLOW
    • 10.2.6. EMULATE
    • 10.2.7. FLUIGENT
    • 10.2.8. HESPEROS
    • 10.2.9. HUREL CORPORATION
    • 10.2.10. INSPHERO AG
    • 10.2.11. MIMETAS B.V.
    • 10.2.12. NORTIS INC.
    • 10.2.13. ORGANOVO HOLDINGS, INC.
    • 10.2.14. SYNVIVO
    • 10.2.15. TARA BIOSYSTEMS, INC.
    • 10.2.16. TISSUSE GMBH

TABLES LIST

  • TABLE 1: GLOBAL ORGAN ON A CHIP MARKET BY REGION 2019-2027 ($ THOUSAND)
  • TABLE 2: GLOBAL ORGAN ON A CHIP MARKET BY ORGAN TYPE 2019-2027 ($ THOUSAND)
  • TABLE 3: GLOBAL ORGAN ON A CHIP MARKET BY APPLICATION 2019-2027 ($ THOUSAND)
  • TABLE 4: GLOBAL ORGAN ON A CHIP MARKET BY END-USER 2019-2027 ($ THOUSAND)
  • TABLE 5: TIME REQUIRED IN THE DRUG DEVELOPMENT PROCESS
  • TABLE 6: RAW MATERIAL SUPPLIERS
  • TABLE 7: MANUFACTURERS OPERATING IN THE ORGAN ON A CHIP MARKET
  • TABLE 8: END-USER OF THE ORGAN ON A CHIP MARKET
  • TABLE 9: GLOBAL ORGAN ON A CHIP MARKET BY REGION 2019-2027 ($ THOUSAND)
  • TABLE 10: NORTH AMERICA ORGAN ON A CHIP MARKET BY COUNTRY 2019-2027 ($ THOUSAND)
  • TABLE 11: EUROPE ORGAN ON A CHIP MARKET BY COUNTRY 2019-2027 ($ THOUSAND)
  • TABLE 12: ASIA PACIFIC ORGAN ON A CHIP MARKET BY COUNTRY 2019-2027 ($ THOUSAND)
  • TABLE 13: REST OF WORLD ORGAN ON A CHIP MARKET BY REGION 2019-2027 ($ THOUSAND)
  • TABLE 14: ORGAN ON A CHIP COMPANY MARKET POSITION ANALYSIS 2018

FIGURES LIST

  • FIGURE 1: GLOBAL ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 2: R&D PROJECTS IN THE PIPELINE OF TOP 20 COMPANIES, 2018
  • FIGURE 3: GLOBAL ORGAN ON A CHIP MARKET SHARE BY ORGAN TYPE 2018 & 2027 (%)
  • FIGURE 4: GLOBAL ORGAN ON A CHIP MARKET BY LIVER 2019-2027 ($ THOUSAND)
  • FIGURE 5: GLOBAL ORGAN ON A CHIP MARKET BY HEART 2019-2027 ($ THOUSAND)
  • FIGURE 6: GLOBAL ORGAN ON A CHIP MARKET BY LUNG 2019-2027 ($ THOUSAND)
  • FIGURE 7: GLOBAL ORGAN ON A CHIP MARKET BY OTHER ORGAN TYPE 2019-2027 ($ THOUSAND)
  • FIGURE 8: GLOBAL ORGAN ON A CHIP MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 9: GLOBAL ORGAN ON A CHIP MARKET BY DRUG DISCOVERY 2019-2027 ($ THOUSAND)
  • FIGURE 10: GLOBAL ORGAN ON A CHIP MARKET BY TOXICOLOGY RESEARCH 2019-2027 ($ THOUSAND)
  • FIGURE 11: GLOBAL ORGAN ON A CHIP MARKET BY OTHER APPLICATION 2019-2027 ($ THOUSAND)
  • FIGURE 12: GLOBAL ORGAN ON A CHIP MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 13: GLOBAL ORGAN ON A CHIP MARKET BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 2019-2027 ($ THOUSAND)
  • FIGURE 14: GLOBAL ORGAN ON A CHIP MARKET BY ACADEMIC AND RESEARCH INSTITUTES 2019-2027 ($ THOUSAND)
  • FIGURE 15: GLOBAL ORGAN ON A CHIP MARKET BY OTHER END-USER 2019-2027 ($ THOUSAND)
  • FIGURE 16: PORTER'S FIVE FORCE MODEL
  • FIGURE 17: DRUG DEVELOPMENT PROCESS
  • FIGURE 18: PHASES OF DRUG DISCOVERY
  • FIGURE 19: SUPPLY CHAIN ANALYSIS OF ORGAN ON A CHIP MARKET
  • FIGURE 20: GLOBAL ORGAN ON A CHIP MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 21: THE UNITED STATES ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 22: CANADA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 23: FRANCE ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 24: GERMANY ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 25: THE UNITED KINGDOM ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 26: ITALY ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 27: SPAIN ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 28: REST OF EUROPE ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 29: JAPAN ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 30: CHINA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 31: INDIA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 32: AUSTRALIA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 33: SOUTH KOREA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 34: REST OF ASIA PACIFIC ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 35: LATIN AMERICA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
  • FIGURE 36: MIDDLE EAST AND AFRICA ORGAN ON A CHIP MARKET 2019-2027 ($ THOUSAND)
Back to Top